Long-term Home Video EEG for Recording Clinical Events

2020 ◽  
Vol 38 (2) ◽  
pp. 92-100
Author(s):  
Shirin Jamal Omidi ◽  
Johnson P. Hampson ◽  
Samden D. Lhatoo
Keyword(s):  
2019 ◽  
Vol 90 (3) ◽  
pp. e19.2-e20
Author(s):  
W Stern ◽  
G Leschziner ◽  
R Howard ◽  
M Koutroumanidis

ObjectivesTo assess the clinical usefulness of HVT over the first 2 years.DesignCohort observational.Subjects60 patients (49 F) with epilepsies or non-epileptic paroxysmal clinical events.Methods48–72 hour continuous video EEG at patients’ own environment.ResultsHVT answered the primary clinical question in 45/60 patients (75%), and provided additional clinical information in 5 patients [2 with unsuspected coexistent psychogenic non-epileptic seizures (PNES) and 3 with unsuspected sleep disorders (SD)]. Of the 12 patients with Idiopathic Generalized Epilepsy, absences had been overestimated in 6 and underestimated in 4, while absence status was recorded in 1 of the 2 patients in whom it had been suspected. Valproate was possible to drastically reduce or stop in 3/6 women. Focal seizures were recorded in 19 of 28 patients with focal epilepsies, PNES were the habitual seizures in further 2 patients, while syndrome classification changed in one. In all 4 patients referred for differentiation between SD and epilepsy, HVT confirmed parasomnias in 2, daytime naps in 1 and idiopathic hypersomnia in 1. The diagnosis of PNES was confirmed in 8 of 13 suspected patients. HVT was unhelpful in the 3 patients referred for not witnessed, poorly understood episodes of loss of consciousness. Three patients switched off the video and 2 failed to change battery on day 2.ConclusionsHVT is a useful diagnostic test provided that diagnostic hypothesis and clinical question are appropriate.


2021 ◽  
pp. practneurol-2020-002910
Author(s):  
Amardeep Kaundal ◽  
V Hegde ◽  
H Khan ◽  
Holger Allroggen

Long-term electroencephalogram monitoring is often used to help distinguish epileptic from dissociative (non-epileptic) seizures. Home video telemetry now offers many of the benefits in diagnosis previously available only with inpatient video telemetry, which is usually regarded as the ‘gold standard’. Here, we describe recent developments in home video telemetry and how we undertake this procedure in our unit.


2021 ◽  
Vol 15 ◽  
pp. 100416
Author(s):  
Mohamed Khalil ◽  
Arif Ali Shukralla ◽  
Ronan Kilbride ◽  
Gerrard Mullins ◽  
Peter Widdess- Walsh ◽  
...  
Keyword(s):  

2012 ◽  
Vol 59 (13) ◽  
pp. E120
Author(s):  
Hiromasa Otake ◽  
Toshiro Shinke ◽  
Junya Shite ◽  
Ken–ichi Hirata

Seizure ◽  
2018 ◽  
Vol 63 ◽  
pp. 48-51 ◽  
Author(s):  
Xi Liu ◽  
Naoum P. Issa ◽  
Sandra Rose ◽  
Shasha Wu ◽  
Taixin Sun ◽  
...  

2016 ◽  
Vol 38 (1) ◽  
pp. 56-59 ◽  
Author(s):  
Maurício Scopel Hoffmann ◽  
Lucas Mendes Oliveira ◽  
Maria Inês Rodrigues Lobato ◽  
Paulo Belmonte-de-Abreu

Objective To describe the case of a patient with schizophrenia on clozapine treatment who had an episode of heat stroke. Case description During a heat wave in January and February 2014, a patient with schizophrenia who was on treatment with clozapine was initially referred for differential diagnose between systemic infection and neuroleptic malignant syndrome, but was finally diagnosed with heat stroke and treated with control of body temperature and hydration. Comments This report aims to alert clinicians take this condition into consideration among other differential diagnoses, especially nowadays with the rise in global temperatures, and to highlight the need for accurate diagnosis of clinical events during pharmacological intervention, in order to improve treatment decisions and outcomes.


Open Heart ◽  
2021 ◽  
Vol 8 (2) ◽  
pp. e001869
Author(s):  
Ingvild Maria Tøllefsen ◽  
Christian Shetelig ◽  
Ingebjørg Seljeflot ◽  
Jan Eritsland ◽  
Pavel Hoffmann ◽  
...  

ObjectiveInflammation has emerged as a new treatment target in patients with coronary artery disease and inflammation seems to play an important role in ischaemia/reperfusion injury that follows ST-elevation myocardial infarction (STEMI). We aimed to explore the role of acute and sustained interleukin 6 (IL-6) signalling, including soluble IL-6 receptor (IL-6R), with regard to infarct size, adverse remodelling and future cardiovascular events in patients with STEMI.MethodsWe included 269 patients with first-time STEMI, symptom duration <6 hours and treated with percutaneous coronary intervention. Blood sampling and cardiac MRI were performed in the acute phase and after 4 months. Clinical events and all-cause mortality were registered during 12-month and 70-month follow-up, respectively.ResultsIL-6 levels above median at all sampling points were significantly associated with increased infarct size and reduced left ventricular ejection fraction (LVEF). IL-6 levels in the highest quartile were at all sampling points associated with an increased risk of having an adverse clinical event during the first 12 months and with long-term all-cause mortality. IL-6R was not associated with infarct size, LVEF, myocardial salvage or long-term all-cause mortality.ConclusionAcute and sustained elevation of IL-6 measured 4 months after STEMI were associated with larger infarct size, reduced LVEF and adverse clinical events including all-cause mortality. The results add important information to the sustained role of inflammation in patients with STEMI and IL-6 as a potential target for long-term intervention.Trial registration numberNCT00922675.


2020 ◽  
Vol 9 (6) ◽  
pp. 1671 ◽  
Author(s):  
Hyung Yoon Kim ◽  
Jong Eun Park ◽  
Sang-Chol Lee ◽  
Eun-Seok Jeon ◽  
Young Keun On ◽  
...  

Background: The spectrum of genetic variants and their clinical significance of Hypertrophic cardiomyopathy (HCM) have been poorly studied in Asian patients. The objectives of this study were to assess the spectrum of genetic variants and genotype–phenotype relationships within a Korean HCM population. Methods: Eighty-nine consecutive unrelated HCM patients were included. All patients underwent genotypic analysis for 23 HCM-associated genes. Clinical parameters including echocardiographic and cardiac magnetic resonance (CMR) parameters were evaluated. A composite of major adverse cardiac and cerebrovascular events was assessed. Results: Genetic variants were detected in 55 of 89 subjects. Pathogenic variants or likely pathogenic variants were identified in 27 of HCM patients in MYBPC3, TNNI3, MYH7, and MYL7. Variants of uncertain significance were identified in 28 patients. There were significant differences in the presence of non-sustained ventricular tachycardia (p = 0.030) and myocardial fibrosis on CMR (p = 0.029) in the detected compared to the not-detected groups. Event-free survival was superior in the not-detected group (p = 0.006). Conclusion: Genetic variants in patients with HCM are relatively common and are associated with adverse clinical events and myocardial fibrosis on CMR. Genotypic analysis may add important information to clinical variables in the assessment of long-term risk for HCM patients.


Sign in / Sign up

Export Citation Format

Share Document